ARCA Biopharma Inc ABIO:NASDAQ

RT Quote | NASDAQ | USD
Last | 04/20/21 EDT
3.30quote price arrow down-0.09 (-2.65%)
Volume
286,844
52 week range
3.20 - 22.00

...

Loading . . .
  • Open3.35
  • Day High3.44
  • Day Low3.28
  • Prev Close3.30
  • 52 Week High22.00
  • 52 Week High Date05/28/20
  • 52 Week Low3.20
  • 52 Week Low Date05/01/20

Key Stats

  • Market Cap47.55M
  • Shares Out14.41M
  • 10 Day Average Volume0.32M
  • Dividend-
  • Dividend Yield-
  • Beta2.74
  • YTD % Change-17.71

KEY STATS

  • Open3.35
  • Day High3.44
  • Day Low3.28
  • Prev Close3.30
  • 52 Week High22.00
  • 52 Week High Date05/28/20
  • 52 Week Low3.20
  • 52 Week Low Date05/01/20
  • Market Cap47.55M
  • Shares Out14.41M
  • 10 Day Average Volume0.32M
  • Dividend-
  • Dividend Yield-
  • Beta2.74
  • YTD % Change-17.71

RATIOS/PROFITABILITY

  • EPS (TTM)-2.43
  • P/E (TTM)-1.36
  • Fwd P/E (NTM)-0.37
  • EBITDA (MRQ)-9.758M
  • ROE (MRQ)-35.98%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date05/08/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From ARCA Biopharma Inc

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
ARCA biopharma, Inc. (ARCA) is a biopharmaceutical company. The Company is principally focused on developing genetically-targeted therapies for cardiovascular diseases. The Company's lead product candidate is Gencaro (bucindolol hydrochloride), a beta-blocker and mild vasodilator that the Company is evaluating in a clinical trial for the treatment of atrial fibrillation (AF) in patients with heart failure with reduced left ventricular ejection fraction (HFREF). Gencaro is...
Robert Conway CPA
Chairman
Michael Bristow M.D., Ph.D.
Chief Executive Officer
Thomas Keuer
Chief Operating Officer
Brian Selby CPA
Chief Accounting Officer
Address
10170 Church Ranch Way, Suite 100
Westminster, CO
80021
United States

Top Peers

SYMBOLLASTCHG%CHG
ADIL
Adial Pharmaceuticals Inc
2.02-0.03-1.46%
CLBS
Caladrius Biosciences Inc
1.49-0.01-0.67%
ACER
Acer Therapeutics Inc
2.65-0.12-4.33%
ARTL
Artelo Biosciences Inc
1.14-0.12-9.52%
BPTH
Bio Path Holdings Inc
5.55+0.03+0.54%
AZRX
AzurRx BioPharma Inc
0.8698+0.0856+10.92%